A recent study found that injectable anticancer drugs steadily increase in price, even after competition enters the market.
A recent study found that injectable anticancer drugs steadily increase in price, even after competition enters the market.
Where clinical, regulatory, and economic perspectives converge—sign up for Center for Biosimilars® emails to get expert insights on emerging treatment paradigms, biosimilar policy, and real-world outcomes that shape patient care.